Tuesday, November 19, 2024
Home 2024

Yearly Archives: 2024

2024 Watch List

Nine Page Summary Report on GeoVax (GOVX)

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Provides First Half 2024 Business Update.

Editor / Curator -
All News

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Editor / Curator -
Biotech News

FDA approves Amgen drug for tough-to-treat form of lung cancer.

Editor / Curator -
2024 Watch List

GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Research Reports Archive

Editor / Curator -
2022 Watch List

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

Editor / Curator -
2024 Watch List

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Editor / Curator -
2024 Watch List

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at...

Editor / Curator -
Biotech News

COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Editor / Curator -
123...6Page 1 of 6

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.